▼
Settlement Not Yet Approved · Nothing to Claim Yet
This article describes a proposed settlement that no court has approved and two other lawsuits whose claims
are unproven allegations. WHOOP has not been found liable in any of these cases, and there is nothing
to claim at this time. This page is informational and is not legal advice.
WHOOP, Inc., the maker of the WHOOP fitness band and its paid membership, has agreed to settle a California class action over how it renewed memberships. A stipulation filed on October 29, 2026 in Sanderson v. Whoop, Inc. (N.D. Cal. No. 3:23-cv-05477) says the parties signed a settlement agreement on October 23, 2026 under which WHOOP will establish and fund an $11 million, non-reversionary cash common fund.
The settlement is not final. The parties told the federal court they will seek approval in a related California Superior Court case, and the federal case was dismissed without prejudice on that basis, with the judge keeping the power to reopen it if the settlement is not finally approved. No notice, claim form, deadline or settlement website has been published.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Settlement Signed · Court Approval Pending
Agreement executed October 23, 2026
Settlement Fund
$11 million
Non-reversionary cash fund · per-person amount not published
Who Is Covered
California WHOOP members charged for an automatic renewal
Based on the class certified in March 2025 · final definition not published
Can I Claim?
No — nothing to claim yet
The case was filed on October 24, 2023. The plaintiff alleges WHOOP enrolled customers in automatically renewing memberships without the clear and conspicuous disclosures and affirmative consent that California’s Automatic Renewal Law requires, and then charged them for renewal terms. WHOOP opposed class certification and sought summary judgment, and the settlement filing contains no admission of wrongdoing.
On March 7, 2025 the court certified a class of people in California who purchased a WHOOP membership through the WHOOP website, were enrolled in an automatically renewing membership, and were automatically renewed and charged for at least one renewal term after their initial membership or commitment period ended. It also certified a subclass of members charged for a renewal term they did not use.
In July 2026 the court declined to grant summary judgment to either side on the plaintiff’s damages claim under the Consumers Legal Remedies Act, which it said could proceed to trial, and dismissed the equitable claims without prejudice to refiling in state court. The court did not find that WHOOP violated the law. The parties mediated on July 23, 2026 and then reached the settlement.
According to the stipulation, the $11 million fund amounts to approximately 39% of the $28.2 million in full-refund damages the plaintiff was seeking. The filing does not say how the money will be divided among class members, how much may go to attorneys’ fees and costs, or whether class members will need to file a claim. Those terms are normally set out in the settlement agreement and notice submitted for preliminary approval, which OCA has not yet seen.
A separate proposed class action, Rowe v. Whoop, Inc., was filed on November 18, 2025 in federal court in the Northern District of California. The plaintiff alleges WHOOP marketed its Blood Pressure Insights feature, part of the WHOOP Life membership and WHOOP MG device, as providing medical-grade blood pressure insights even though the FDA had not authorized it. The proposed class is California purchasers of the product in the four years before the suit. The claims are unproven.
The complaint relies on an FDA warning letter to WHOOP dated July 14, 2025, which said the agency had not authorized Blood Pressure Insights for any use. The FDA closed out that letter on June 17, 2026, stating that, based on changes WHOOP made to the feature and its labeling, it did not intend to enforce device requirements for the product as modified.
WHOOP moved to compel arbitration in the case. OCA has not found a ruling on that motion, a dismissal or a settlement.
In Lomeli v. WHOOP, Inc., filed on August 13, 2025 in the same federal district, the plaintiff alleges the WHOOP mobile app included a third-party analytics tool called Segment and disclosed users’ personal details, health metrics and the titles of videos they watched without consent. The complaint asserts claims under the federal Video Privacy Protection Act and California’s Confidentiality of Medical Information Act.
On November 5, 2026 the court granted WHOOP’s motion to compel arbitration and stayed the case. The order rests on WHOOP’s terms of use and does not decide whether the allegations are true.
The auto-renewal settlement must be presented to the California Superior Court for preliminary approval. If the court grants it, class members would receive notice describing who is covered, what they can receive and any deadlines. OCA will update this page when a court acts on the settlement or a settlement website is published.
Is there a WHOOP class action settlement?
Yes, in one case. Court filings show WHOOP signed a settlement agreement on October 23, 2026 in Sanderson v. Whoop, Inc., a California auto-renewal class action, under which it will fund an $11 million non-reversionary cash fund. The settlement has not been approved by a court, and no claim form, notice or settlement website has been published.
Who is covered by the WHOOP auto-renewal settlement?
The settlement’s final class definition has not been published. The class the federal court certified in March 2025 covers people in California who bought a WHOOP membership through the WHOOP website, were enrolled in an automatically renewing membership, and were renewed and charged for at least one renewal term after their initial membership or commitment period ended.
How much will WHOOP members receive?
No per-person amount has been published. The filing describes an $11 million fund, which it says is about 39% of the $28.2 million in full-refund damages the plaintiff sought. How the fund is divided, and what comes out of it for fees and costs, will be set out in the settlement papers submitted for court approval.
What happened to the WHOOP blood pressure lawsuit?
Rowe v. Whoop, Inc., filed November 18, 2025 in federal court in California, alleges WHOOP marketed its Blood Pressure Insights feature as medical-grade without FDA authorization. WHOOP moved to compel arbitration. OCA has not found a ruling on that motion, a dismissal or a settlement. The FDA closed out its July 2025 warning letter on June 17, 2026 after WHOOP changed the feature and its labeling.
What happened to the WHOOP privacy lawsuit?
In Lomeli v. WHOOP, Inc., filed August 13, 2025, the plaintiff alleges the WHOOP app shared personal details, health metrics and video titles with a third-party analytics tool called Segment without consent. On November 5, 2026 the court sent the case to arbitration and stayed it, without ruling on whether the allegations are true.
• Stipulation and order dismissing case without prejudice, Sanderson v. Whoop, Inc., No. 3:23-cv-05477 (N.D. Cal. Oct. 29, 2026)
• Order on class certification, Sanderson v. Whoop, Inc. (N.D. Cal. Mar. 7, 2025)
• Order on summary judgment, Sanderson v. Whoop, Inc. (N.D. Cal. July 2026)
• Complaint, Rowe v. Whoop, Inc. (N.D. Cal., filed Nov. 18, 2025)
• FDA warning letter to WHOOP, Inc., July 14, 2025
• FDA close-out letter to WHOOP, Inc., June 17, 2026
• Order granting motion to compel arbitration, Lomeli v. WHOOP, Inc., No. 3:25-cv-06828 (N.D. Cal. Nov. 5, 2026)
For more class actions keep scrolling below.
Status
Settlement signed October 23, 2026; court approval pending
Case Title
Sanderson v. Whoop, Inc.
Case Number
3:23-cv-05477 (N.D. Cal.); 26CU040807N (California Superior Court)
Court
U.S. District Court, Northern District of California; California Superior Court
Date Filed
October 24, 2023
Settlement Fund
$11 million